Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis

It is well known that staging of patients with AL amyloidosis at diagnosis predicts for survival, but there is a paucity of literature delineating the prognostic value of these systems at relapse. We evaluated the prognostic value of AL staging among 413 patients initiated with second-line therapy b...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2019-05, Vol.33 (5), p.1268-1272
Hauptverfasser:	Hwa, Yi L., Gertz, Morie A., Kumar, Shaji K., Lacy, Martha Q., Buadi, Francis K., Dingli, David, Kapoor, Prashant, Zeldenrust, Steve R., Leung, Nelson, Hayman, Susanne R., Gonsalves, Wilson I., Kourelis, Taxiarchis V., Warsame, Rahma, Go, Ronald S., Muchtar, Eli, Hobbs, Miriam A., Fonder, Amie L., Russell, Stephen, Kyle, Robert A., Rajkumar, S. Vincent, Dispenzieri, Angela
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/1990/804 692/699/1541/1990/804 Aged Amyloidosis Antineoplastic Combined Chemotherapy Protocols - therapeutic use Autografts Cancer Research Clinical trials Critical Care Medicine Diagnosis Female Hematology Humans Immunoglobulin Light-chain Amyloidosis - diagnosis Immunoglobulin Light-chain Amyloidosis - drug therapy Immunoglobulin Light-chain Amyloidosis - mortality Intensive Internal Medicine Kaplan-Meier Estimate Male Medical prognosis Medical research Medicine Medicine & Public Health Middle Aged Multivariate analysis Neoplasm Staging Oncology Prognosis Retreatment Retrospective Studies Risk factors Stem cell transplantation Stem cells Survival Systems analysis Therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!